Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
GREE
|
Christian Mulvihill
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 615 Reduced 0.62% |
$836
$1.36 p/Share
|
Aug 13
2025 |
BCDA
|
Peter Altman
President and CEO |
BUY
Open market or private purchase
|
Direct | 100 Added 0.06% |
$183
$1.83 p/Share
|
Aug 13
2025 |
BHC
|
John Paulson |
BUY
Open market or private purchase
|
Indirect | 86,409 Added 0.0% |
$610,047
$7.06 p/Share
|
Aug 13
2025 |
ZG
|
Lloyd D Frink
Co -Exec. Chairman & President |
SELL
Open market or private sale
|
Direct | 3,334 Reduced 0.14% |
$277,022
$83.09 p/Share
|
Aug 13
2025 |
MKZR
|
Christine Elizabeth Simpson
Chief Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.0% |
$9,840
$4.92 p/Share
|
Aug 13
2025 |
CVNA
|
Ernest C. Garcia Iii
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$3,479,600
$347.96 p/Share
|
Aug 13
2025 |
HALO
|
Helen Torley
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 2.65% |
$1,289,800
$64.49 p/Share
|
Aug 13
2025 |
MKZR
|
Angche Sherpa
Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.0% |
$9,840
$4.92 p/Share
|
Aug 13
2025 |
MDGL
|
Paul A Friedman
Director |
SELL
Open market or private sale
|
Direct | 129,172 Reduced 40.83% |
$47,314,411
$366.29 p/Share
|
Aug 13
2025 |
WDC
|
Vidyadhara K Gubbi
Chief of Global Ops |
SELL
Open market or private sale
|
Direct | 5,597 Reduced 3.49% |
$426,827
$76.26 p/Share
|
Aug 13
2025 |
MKZR
|
Jeri Ruth Bluth
Chief Compliance Officer |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.0% |
$9,840
$4.92 p/Share
|
Aug 13
2025 |
CHCI
|
James A Maccutcheon |
SELL
Open market or private sale
|
Direct | 3,630 Reduced 2.47% |
$54,776
$15.09 p/Share
|
Aug 13
2025 |
MKZR
|
Glen W Fuller
Treasurer |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.0% |
$9,840
$4.92 p/Share
|
Aug 13
2025 |
MKZR
|
Charles E. Patterson Ii
General Counsel/Secretary |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.0% |
$9,840
$4.92 p/Share
|
Aug 13
2025 |
MKZR
|
Robert E Dixon
CEO/President |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.0% |
$9,840
$4.92 p/Share
|
Aug 13
2025 |
RPD
|
Jana Partners Management, LP
Director |
BUY
Open market or private purchase
|
Indirect | 250,000 Added 0.0% |
$5,315,000
$21.26 p/Share
|
Aug 13
2025 |
WTS
|
Joseph T Noonan
Director |
SELL
Open market or private sale
|
Direct | 713 Reduced 37.39% |
$195,682
$274.45 p/Share
|
Aug 13
2025 |
ASPN
|
Santhosh P Daniel
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 10.06% |
$15,080
$7.54 p/Share
|
Aug 13
2025 |
HTA
|
Thomas N Bohjalian
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 11.69% |
$164,600
$16.46 p/Share
|
Aug 13
2025 |
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 218,250 Reduced 0.0% |
$1,946,790
$8.92 p/Share
|
Aug 13
2025 |
SHIM
|
Mitchell B. Goldsteen |
SELL
Open market or private sale
|
Indirect | 8,000 Reduced 0.0% |
$16,800
$2.1 p/Share
|
Aug 13
2025 |
CMPO
|
Kevin M Moriarty
Director |
BUY
Open market or private purchase
|
Direct | 13,000 Added 50.0% |
$250,640
$19.28 p/Share
|
Aug 13
2025 |
LNN
|
Robert E Brunner |
SELL
Open market or private sale
|
Direct | 1,332 Reduced 34.33% |
$189,250
$142.08 p/Share
|
Aug 13
2025 |
LNN
|
Robert E Brunner |
SELL
Open market or private sale
|
Indirect | 1,856 Reduced 0.0% |
$263,700
$142.08 p/Share
|
Aug 13
2025 |
DAN
|
James D Kellett
VP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 11,728 Reduced 100.0% |
$218,961
$18.67 p/Share
|
Aug 13
2025 |
SNX
|
Ann F Vezina
Director |
SELL
Open market or private sale
|
Direct | 812 Reduced 11.78% |
$122,141
$150.42 p/Share
|
Aug 13
2025 |
H
|
Mark R Vondrasek
Officer |
SELL
Open market or private sale
|
Direct | 2,337 Reduced 25.03% |
$327,881
$140.3 p/Share
|
Aug 13
2025 |
LLY
|
Jacob Van Naarden
EVP & Pres., Lilly Oncology |
BUY
Open market or private purchase
|
Direct | 1,000 Added 4.64% |
$647,360
$647.36 p/Share
|
Aug 13
2025 |
WINA
|
Gina Decaro Sprenger |
BUY
Open market or private purchase
|
Direct | 250 Added 50.0% |
$102,692
$410.77 p/Share
|
Aug 13
2025 |
TLS
|
Bradley W. Jacobs
Director |
SELL
Open market or private sale
|
Direct | 60,000 Reduced 21.95% |
$313,200
$5.22 p/Share
|
Aug 13
2025 |
ETG
|
Derek Di Gregorio |
SELL
Open market or private sale
|
Indirect | 800 Reduced 0.0% |
$16,600
$20.75 p/Share
|
Aug 13
2025 |
MDRR
|
Charles Brent Winn Jr.
CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct | 909 Added 1.64% |
$9,844
$10.83 p/Share
|
Aug 13
2025 |
RHP
|
Colin V Reed
Exec. Chairman of the Board |
BUY
Open market or private purchase
|
Direct | 8,611 Added 0.97% |
$819,853
$95.21 p/Share
|
Aug 13
2025 |
NRGV
|
Larry Paulson
Director |
BUY
Open market or private purchase
|
Direct | 20,000 Added 6.34% |
$27,599
$1.38 p/Share
|
Aug 13
2025 |
TSBK
|
David Alan Smith
Director |
SELL
Open market or private sale
|
Direct | 164 Reduced 0.91% |
$5,494
$33.5 p/Share
|
Aug 13
2025 |
SHBI
|
Konrad Wayson
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 0.0% |
$16,020
$16.02 p/Share
|
Aug 13
2025 |
GLO
|
Clifford John Weber |
BUY
Open market or private purchase
|
Direct | 2,300 Added 50.0% |
$12,719
$5.53 p/Share
|
Aug 13
2025 |
ESTA
|
Nicholas Sheridan Lewin
Director |
BUY
Open market or private purchase
|
Indirect | 2,300 Added 0.0% |
$78,890
$34.3 p/Share
|
Aug 13
2025 |
TPVG
|
James Labe
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 28,387 Added 0.0% |
$178,270
$6.28 p/Share
|
Aug 12
2025 |
PKBK
|
Ralph Martin Gallo
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,946 Reduced 100.0% |
$42,597
$21.89 p/Share
|
Aug 12
2025 |
GEVO
|
Angelo Amorelli |
SELL
Open market or private sale
|
Direct | 183,515 Reduced 90.43% |
$357,854
$1.95 p/Share
|
Aug 12
2025 |
ESNT
|
Mary Lourdes Gibbons
SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,760 Reduced 1.5% |
$233,120
$62.0 p/Share
|
Aug 12
2025 |
LPSN
|
Vector Capital Management, L.P. |
SELL
Open market or private sale
|
Indirect | 706,991 Reduced 0.0% |
$721,130
$1.02 p/Share
|
Aug 12
2025 |
FUBO
|
Daniel V Leff
Director |
SELL
Open market or private sale
|
Indirect | 59,694 Reduced 0.0% |
$216,092
$3.62 p/Share
|
Aug 12
2025 |
FUBO
|
Edgar Bronfman Jr
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 59,694 Reduced 0.0% |
$216,092
$3.62 p/Share
|
Aug 12
2025 |
QBTS
|
John M. Markovich
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 6.03% |
$1,800,000
$18.0 p/Share
|
Aug 12
2025 |
UTI
|
Robert Thomas Devincenzi |
BUY
Open market or private purchase
|
Direct | 10,000 Added 6.81% |
$254,000
$25.4 p/Share
|
Aug 12
2025 |
DNLI
|
Carole Ho
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,937 Reduced 1.33% |
$39,884
$13.58 p/Share
|
Aug 12
2025 |
DNLI
|
Alexander O. Schuth
COFO and Secretary |
SELL
Open market or private sale
|
Direct | 2,937 Reduced 1.2% |
$39,884
$13.58 p/Share
|
Aug 12
2025 |
OMI
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 720,000 Added 0.0% |
$3,708,000
$5.15 p/Share
|
Aug 12
2025 |